ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32935-1mg |
|
149606-27-9 |
Soblidotin (Auristatin PE)
|
0 | C39H67N5O6 | |
GC32935-10mM(1mLinDMSO) |
|
149606-27-9 |
Soblidotin (Auristatin PE)
|
0 | C39H67N5O6 | |
GC32934-100mg |
|
737789-87-6 |
Relugolix (TAK-385)
|
0 | C29H27F2N7O5S | |
GC32934-50mg |
|
737789-87-6 |
Relugolix (TAK-385)
|
0 | C29H27F2N7O5S | |
GC32934-10mg |
|
737789-87-6 |
Relugolix (TAK-385)
|
0 | C29H27F2N7O5S | |
GC32934-5mg |
|
737789-87-6 |
Relugolix (TAK-385)
|
0 | C29H27F2N7O5S | |
GC32934-1mg |
|
737789-87-6 |
Relugolix (TAK-385)
|
0 | C29H27F2N7O5S | |
GC32934-10mM(1mLinDMSO) |
|
737789-87-6 |
Relugolix (TAK-385)
|
0 | C29H27F2N7O5S | |
GC32933-100mg |
|
1454925-59-7 |
NXT629
|
0 | C35H39N5O3S | |
GC32933-50mg |
|
1454925-59-7 |
NXT629
|
0 | C35H39N5O3S | |
GC32933-25mg |
|
1454925-59-7 |
NXT629
|
0 | C35H39N5O3S | |
GC32933-10mg |
|
1454925-59-7 |
NXT629
|
0 | C35H39N5O3S | |
GC32933-5mg |
|
1454925-59-7 |
NXT629
|
0 | C35H39N5O3S | |
GC32933-10mM(1mLinDMSO) |
|
1454925-59-7 |
NXT629
|
0 | C35H39N5O3S | |
GC32932-50mg |
|
1523404-29-6 |
Vps34-IN-2
|
0 | C18H25F3N4O3 | |
GC32932-25mg |
|
1523404-29-6 |
Vps34-IN-2
|
0 | C18H25F3N4O3 | |
GC32932-10mg |
|
1523404-29-6 |
Vps34-IN-2
|
0 | C18H25F3N4O3 | |
GC32932-5mg |
|
1523404-29-6 |
Vps34-IN-2
|
0 | C18H25F3N4O3 | |
GC32932-1mg |
|
1523404-29-6 |
Vps34-IN-2
|
0 | C18H25F3N4O3 | |
GC32932-10mM(1mLinDMSO) |
|
1523404-29-6 |
Vps34-IN-2
|
0 | C18H25F3N4O3 | |